Unbound MEDLINE

Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO [Ann Oncol] Journal article

 
TitlePremedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy.
Author(s)Kanai M, Matsumoto S, Nishimura T, Matsumura Y, Hatano E, Mori A, Masui T, Kawaguchi Y, Nakamura E, Tada S, Kitano T, Ishiguro H, Yanagihara K, Chiba T 
InstitutionOutpatient Oncology Unit.
SourceAnn Oncol 2009 Nov 4.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19889615
  
Advertise on this site.